0001493152-22-037141.txt : 20221230 0001493152-22-037141.hdr.sgml : 20221230 20221230160626 ACCESSION NUMBER: 0001493152-22-037141 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221229 FILED AS OF DATE: 20221230 DATE AS OF CHANGE: 20221230 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vander Hoek Michael CENTRAL INDEX KEY: 0001945351 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41488 FILM NUMBER: 221502050 MAIL ADDRESS: STREET 1: SHUTTLE PHARMACEUTICALS HOLDINGS, INC. STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shuttle Pharmaceuticals Holdings, Inc. CENTRAL INDEX KEY: 0001757499 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE RESEARCH COURT STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 2404034212 MAIL ADDRESS: STREET 1: ONE RESEARCH COURT STREET 2: SUITE 450 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 ownership.xml X0306 4 2022-12-29 0 0001757499 Shuttle Pharmaceuticals Holdings, Inc. SHPH 0001945351 Vander Hoek Michael C/O SHUTTLE PHARMACEUTICALS HOLDINGS ONE RESEARCH COURT, SUITE 450 ROCKVILLE MD 20850 0 1 0 0 Chief Financial Officer COMMON STOCK 2022-12-29 4 S 0 2243 1.605 D 3852 D Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6,095 restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person. Consists of 3,852 shares of SHPH common stock. /s/ Michael Vander Hoek 2022-12-30